Intestinal Secretion: Stimulation by Peptides, Science, vol.174, issue.4007, pp.422-426, 1971. ,
DOI : 10.1126/science.174.4007.422
Signal Transduction in Gastrointestinal Smooth Muscle, Cellular Signalling, vol.9, issue.3-4, pp.269-76, 1997. ,
DOI : 10.1016/S0898-6568(96)00180-5
Expression of pituitary adenylate cyclase-activating polypeptide and PACAP type 1 receptor in the rat gastric and colonic myenteric neurons, Regulatory Peptides, vol.105, issue.3, pp.145-154, 2002. ,
DOI : 10.1016/S0167-0115(02)00003-4
Gastrointestinal dysfunction in mice with a targeted mutation in the gene encoding vasoactive intestinal polypeptide: A model for the study of intestinal ileus and Hirschsprung's disease, Peptides, vol.28, issue.9, pp.1688-1689, 2007. ,
DOI : 10.1016/j.peptides.2007.05.006
Age-dependent association of idiopathic achalasia with vasoactive intestinal peptide receptor 1 gene, Neurogastroenterology & Motility, vol.10, issue.1 Pt 1, pp.597-602, 2009. ,
DOI : 10.1111/j.1365-2982.2009.01284.x
Regulation of TLR expression, a new perspective for the role of VIP in immunity, Peptides, vol.28, issue.9, pp.1825-1832, 2007. ,
DOI : 10.1016/j.peptides.2007.07.005
Regulation of immune tolerance by anti-inflammatory neuropeptides, Nature Reviews Immunology, vol.1070, issue.1, pp.52-63, 2007. ,
DOI : 10.1038/nri1984
Vasoactive Intestinal Peptide Regulates Th17 Function in Autoimmune Inflammation, Neuroimmunomodulation, vol.14, issue.3-4, pp.134-138, 2007. ,
DOI : 10.1159/000110636
Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren's syndrome, Annals of the Rheumatic Diseases, vol.65, issue.2, pp.195-200, 2006. ,
DOI : 10.1136/ard.2005.038232
Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis, Arthritis & Rheumatism, vol.201, issue.3, pp.864-876, 2006. ,
DOI : 10.1002/art.21652
Molecular pharmacology and structure of VPAC Receptors for VIP and PACAP, Regulatory Peptides, vol.108, issue.2-3, pp.165-73, 2002. ,
DOI : 10.1016/S0167-0115(02)00099-X
Structure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene., Proceedings of the National Academy of Sciences, vol.92, issue.7, pp.2939-2982, 1995. ,
DOI : 10.1073/pnas.92.7.2939
Selective Gene Expression and Activation-Dependent Regulation of Vasoactive Intestinal Peptide Receptor Type 1 and Type 2 in Human T Cells, The Journal of Immunology, vol.166, issue.4, pp.2522-2530, 2001. ,
DOI : 10.4049/jimmunol.166.4.2522
Vasoactive intestinal peptide induces IL-8 production in human colonic epithelial cells via MAP kinase-dependent and PKA-independent pathways, Biochemical and Biophysical Research Communications, vol.317, issue.1, pp.187-91, 2004. ,
DOI : 10.1016/j.bbrc.2004.03.033
VIP attenuation of the severity of experimental pancreatitis is due to VPAC1 receptor-mediated inhibition of cytokine production, Pancreas, vol.30, pp.62-70, 2005. ,
Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells, Blood, vol.107, issue.9, pp.3632-3640, 2006. ,
DOI : 10.1182/blood-2005-11-4497
Induction of Alloantigen-Specific Human T Regulatory Cells by Vasoactive Intestinal Peptide, The Journal of Immunology, vol.183, issue.7, pp.4346-59, 2009. ,
DOI : 10.4049/jimmunol.0900400
Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: Altered expression and signal in immune cells, Arthritis & Rheumatism, vol.71, issue.4, pp.1010-1019, 2008. ,
DOI : 10.1002/art.23482
A functional polymorphism of the vasoactive intestinal peptide receptor 1 gene correlates with the presence of HLA-B???*2705 in Sardinia, Genes and Immunity, vol.113, issue.8, pp.659-67, 2008. ,
DOI : 10.1016/j.jneuroim.2007.01.020
Small RNAs: Regulators and guardians of the genome, Journal of Cellular Physiology, vol.17, issue.2, pp.412-421, 2007. ,
DOI : 10.1002/jcp.21230
Dicing and slicing, FEBS Letters, vol.9, issue.26, pp.5822-5831, 2005. ,
DOI : 10.1016/j.febslet.2005.08.079
Specificity of microRNA target selection in translational repression, Genes & Development, vol.18, issue.5, pp.504-515, 2004. ,
DOI : 10.1101/gad.1184404
Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets, Cell, vol.120, issue.1, pp.15-20, 2005. ,
DOI : 10.1016/j.cell.2004.12.035
MicroRNA in autoimmunity and autoimmune diseases, Journal of Autoimmunity, vol.32, issue.3-4, pp.189-94, 2009. ,
DOI : 10.1016/j.jaut.2009.02.012
Dicer-dependent microRNA pathway safeguards regulatory T cell function, The Journal of Experimental Medicine, vol.205, issue.9, pp.1993-2004, 2008. ,
DOI : 10.1038/ng1744
SiLEncing SLE: the power and promise of small noncoding RNAs, Current Opinion in Rheumatology, vol.20, issue.5, pp.526-557, 2008. ,
DOI : 10.1097/BOR.0b013e328304b45e
MicroRNAs, the immune system and rheumatic disease, Nature Clinical Practice Rheumatology, vol.8, issue.10, pp.534-575, 2008. ,
DOI : 10.1038/ncprheum0885
Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis, Arthritis & Rheumatism, vol.179, issue.Suppl, pp.1001-1010, 2008. ,
DOI : 10.1002/art.23386
An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes, Blood, vol.115, issue.2, pp.265-273, 2010. ,
DOI : 10.1182/blood-2009-06-225987
Lipopolysaccharide-induced tumor necrosis factor alpha production by human monocytes involves the raf-1/MEK1-MEK2/ERK1-ERK2 pathway, Infect Immun, vol.67, pp.3824-3829, 1999. ,
Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression, Blood, vol.98, issue.5, pp.1429-1439, 2001. ,
DOI : 10.1182/blood.V98.5.1429
Protease inhibitors block lipopolysaccharide induction of tissue factor gene expression in human monocytic cells by preventing activation of c-Rel/p65 heterodimers, J Biol Chem, vol.269, pp.26363-26370, 1994. ,
SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase, Proceedings of the National Academy of Sciences, vol.98, issue.24, pp.13681-13686, 2001. ,
DOI : 10.1073/pnas.251194298
Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia, Blood, vol.109, issue.11, pp.4944-4951, 2007. ,
DOI : 10.1182/blood-2006-12-062398
MicroRNA-managing the TH-17 inflammatory response, Nature Immunology, vol.181, issue.12, pp.1229-1231, 2009. ,
DOI : 10.1038/nm1715
miR-146a Is Critical for Endotoxin-induced Tolerance: IMPLICATION IN INNATE IMMUNITY, Journal of Biological Chemistry, vol.284, issue.50, pp.34590-99, 2009. ,
DOI : 10.1074/jbc.M109.056317
miR-155 Inhibition Sensitizes CD4+ Th Cells for TREG Mediated Suppression, PLoS ONE, vol.102, issue.9, p.7158, 2009. ,
DOI : 10.1371/journal.pone.0007158.s006
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs, Nature, vol.22, issue.7027, pp.769-773, 2005. ,
DOI : 10.1016/S0092-8674(00)00015-5
The Widespread Impact of Mammalian MicroRNAs on mRNA Repression and Evolution, Science, vol.310, issue.5755, pp.1817-1821, 2005. ,
DOI : 10.1126/science.1121158
Human polymorphism at microRNAs and microRNA target sites, Proceedings of the National Academy of Sciences, vol.104, issue.9, pp.3300-3305, 2007. ,
DOI : 10.1073/pnas.0611347104
MicroRNA target site polymorphisms and human disease, Trends in Genetics, vol.24, issue.10, pp.489-497, 2008. ,
DOI : 10.1016/j.tig.2008.07.004
TLR signaling pathways, Seminars in Immunology, vol.16, issue.1, pp.3-9, 2004. ,
DOI : 10.1016/j.smim.2003.10.003